Treatment limited neurocysticercosis in an incarcerated 24-year-old male: A case illustration Authors: Katia Castillo, Jacob Morgan, Praveen Budde Published: 2026 ABSTRACT AbstractNeurocysticercosis (NCC) is a parasitic infection of the central nervous system caused by the larval stage of Taenia solium. Individuals migrating from or traveling to endemic regions may acquire the infection through ingestion of undercooked pork or consumption of water contaminated with T. solium eggs. Although relatively uncommon in the United States, clinical suspicion should be heightened in patients with relevant epidemiologic exposure who present with seizures, signs of increased intracranial pressure, recurrent headaches, or decreased visual acuity with papilledema. Diagnosis is established through neuroimaging, including computed tomography (CT) and magnetic resonance imaging (MRI), often supplemented by serologic testing. Management requires a multidisciplinary approach, incorporating ophthalmologic evaluation to rule out intraocular cysts prior to initiating antiparasitic therapy, along with adjunctive corticosteroids and antiseizure medication. We present the case of a 24-year-old incarcerated male who experienced a generalized tonic-clonic seizure. MRI revealed multiple ring-enhancing cystic lesions with surrounding vasogenic edema, leading to a diagnosis of NCC. Treatment was delayed due to unavailability of in-house ophthalmology capable of performing a fundoscopic examination. Given the patient’s status as a ward of the state, coordination with the detaining law enforcement agency was required to facilitate ophthalmologic assessment and ensure continuity of care. Additionally, medical interpretation services were utilized to provide bilingual discharge instruction emphasizing the need for follow-up ophthalmologic evaluation, antiparasitic and corticosteroid therapy, and repeat brain MRI in six months to assess lesion resolution.Keywords: Neurocysticercosis, Treatment limitations, Immigration Description of case Neurocysticercosis (NCC), caused by the larval stage of Taenia solium, remains the leading preventable cause of epilepsy worldwide and should be considered in patients with new-onset seizures and epidemiologic risk factors, even in the United States [1], [2]. Diagnosis relies on neuroimaging and may be supported by serologic testing, while management requires careful coordination due to the risk of inflammatory complications and vision loss [3]. A 24-year-old incarcerated male presented after a witnessed generalized tonic-clonic seizure. On arrival, he was postictal but neurologically intact, reporting persistent bitemporal headache and nausea. He was started on levetiracetam for seizure prophylaxis. Coronal T1-weighted MRI of the brain demonstrated multiple ring-enhancing cystic lesions with surrounding vasogenic edema (arrows), consistent with NCC. Serum IgG testing for T. solium supported the diagnosis. Definitive antiparasitic therapy was deferred due to the absence of immediate ophthalmologic evaluation. Current guidelines recommend fundoscopic examination prior to initiating antiparasitic treatment, as undiagnosed intraocular cysticerci may lead to irreversible blindness following therapy-induced inflammation [3]. This posed a significant barrier in our rural setting, where in-house ophthalmology services were unavailable. Additionally, as a ward of the state, the patient required coordination with correctional authorities to obtain off-site specialty care. Care was further complicated by language barriers and anticipated discontinuity of care related to incarceration logistics. Medical interpretation services were used throughout hospitalization, and discharge instructions were provided bilingually, emphasizing the urgency of ophthalmologic evaluation prior to initiating albendazole-based therapy, continuation of antiepileptic medication, and follow-up neuroimaging. This case highlights the diagnostic clarity yet therapeutic delay that can occur in NCC when non-medical barriers intersect with guideline-driven care. Although neuroimaging and serology allowed prompt diagnosis, treatment was limited by restricted access to ophthalmologic evaluation, a prerequisite for safe therapy initiation. NCC management therefore extends beyond clinical decision-making and requires coordination across healthcare, legal, and social systems. Early recognition, adherence to guideline-based precautions, and proactive discharge planning are critical to mitigate preventable complications in vulnerable populations. CRediT authorship contribution statement Katia Castillo: Writing – original draft, Investigation, Conceptualization. Jacob Morgan: Writing – review & editing, Investigation. Praveen Budde: Supervision, Resources. Declaration of Funds and External Support No external funds or support were received for the production of this manuscript. Conflict of Interest The authors of this manuscript have no conflicts to disclose. This article was made without the support of external help or financial contribution. The work herein was produced in full by the listed authors. Declaration of Competing Interest All authors confirm there are no competing interests, financial or otherwise. References